PATIENT REPORTED OUTCOMES-CORE SHARED RESOURCE The Patient Reported Outcomes-Core Shared Resource (PRO-core) was developed in response to a growing number of cancer center investigators who require methodological consulting related to survey development, use, and analysis, as well as use of a customizable electronic data capture tool for collecting information directly from patients and other stakeholders. PRO Core provides a software platform and scientific consultation to investigators conducting PRO research. This includes clinical trials of new drugs, interventions with symptom and quality of life endpoints, and studies of the integration of PRO assessment into clinical care. Dr. Bennett is the faculty director and an Associate Professor of Health Policy and Management. She contributed as an investigator to the development and validation of the NCI Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). In fiscal year 2019, the SR was used by 27 faculty, 67% of whom were LCCC members. Importantly, the SR supports highly sophisticated methodology and is a national leader in Patient Reported Outcomes. These skills and methods allow the SR to support external cancer collaborators at multi-site trial locations such as Duke Cancer Institute, Emory University, Georgetown, and Moffit. PRO is requesting $111,249 for this SR which is approximately 39% of its fiscal year 2020 Operating budget. PRO Core has been a successful SR as demonstrated by the following metrics. PRO Core studies are supported by 11 NIH grants (5 from NCI, including 1 K award) and 3 Patient-Centered Outcomes Research Institute (PCORI) contracts. Studies are also supported by Genentech, the Breast Cancer Research Foundation, and pilot awards from the Alliance for Clinical Trials in Oncology cooperative group. PRO Core is supporting a growing portfolio of: 1) studies evaluating the implementation of PRO assessment in oncology care, and 2) studies collecting both PRO data and wearable / activity tracker (e.g. Garmin, Fitbit) data. PRO Core has developed technical capability and expertise in these areas, and the LCCC is now known for substantial scientific leadership in these two areas. In addition, PRO Core is supporting studies that evaluate the comparative effectiveness of new treatments and a new registry that tracks opioid need and use among post-operative patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089834
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Cameron, Jennifer E; Rositch, Anne F; Vielot, Nadja A et al. (2018) Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers. Sex Transm Dis 45:666-672
Lim, Joseph K; Liapakis, Ann Marie; Shiffman, Mitchell L et al. (2018) Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clin Gastroenterol Hepatol 16:1811-1819.e4
Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D et al. (2018) Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Sci Rep 8:3199
Phillips, Bonnie; Van Rompay, Koen K A; Rodriguez-Nieves, Jennifer et al. (2018) Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. J Virol 92:
Lianga, Noel; Doré, Carole; Kennedy, Erin K et al. (2018) Cdk1 phosphorylation of Esp1/Separase functions with PP2A and Slk19 to regulate pericentric Cohesin and anaphase onset. PLoS Genet 14:e1007029
Allott, Emma H; Geradts, Joseph; Cohen, Stephanie M et al. (2018) Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res 20:12
Dhungel, Bal Mukunda; Montgomery, Nathan D; Painschab, Matthew S et al. (2018) 'Discovering' primary effusion lymphoma in Malawi. AIDS 32:2264-2266
Puvanesarajah, Samantha; Nyante, Sarah J; Kuzmiak, Cherie M et al. (2018) PAM50 and Risk of Recurrence Scores for Interval Breast Cancers. Cancer Prev Res (Phila) 11:327-336
Stanley, Christopher C; van der Gronde, Toon; Westmoreland, Kate D et al. (2018) Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi. Support Care Cancer 26:967-973
Dronamraju, Raghuvar; Jha, Deepak Kumar; Eser, Umut et al. (2018) Set2 methyltransferase facilitates cell cycle progression by maintaining transcriptional fidelity. Nucleic Acids Res 46:1331-1344

Showing the most recent 10 out of 1525 publications